Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Talecris Biotherapeutics Holdings Corp. (TLCR)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
06/01/2011
PRN
Grifols and Talecris Biotherapeutics Announce the FTC Has Accepted the Consent Agreement for Public Comment
05/02/2011
PRN
Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement with FTC Staff
03/04/2011
PRN
Talecris Biotherapeutics Announces Record Date for 2011 Annual Meeting of Shareholders
03/04/2011
PRN
Grifols and Talecris Announce the Outside Date of Their Merger Agreement has been Extended to June 30, 2011
03/03/2011
PRN
Talecris Biotherapeutics Receives EU Orphan Drug Designation for Plasmin (Human) as a Treatment for Acute Peripheral Arterial Occlusion
02/15/2011
PRN
NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
02/14/2011
PRN
Talecris Shareholders Approve Merger with Grifols During Special Meeting of Shareholders
02/08/2011
PRN
Talecris Biotherapeutics to Report Fourth Quarter and Full Year 2010 Financial Results
07/16/2010
PRN
Talecris Biotherapeutics to Report Second Quarter 2010 Financial Results
07/08/2010
PRN
Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy